Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.5 , No. 1, Publication Date: Jan. 18, 2018, Page: 10-13
, and magnetic resonance imaging, while the other just CT scan, both inexpressive. The etiologic diagnose were idiopathic and secondary to acute rhinitis, respectively. Both patients had been treated with topical steroids and anti-histaminic drugs. Our treatment of this condition was dietary integration with galactose (1.5 g), reduced glutathione (0.1 g) and Ubiquinone (Coenzyme Q10, 0.1 g). For assessment of response to treatment, the Italian version of the University of Pennsylvania Smell Identification Test was used. After two months treatment the older patient completely recovered smell and was also able to appreciate some tastes. The younger patient, after one-month treatment experienced cacosmia, and some phantosmia, but after one more month treatment, such symptoms disappeared and he recovered partially normal smell and gustative function. In both cases, the recovery is stable, until now. Results suggest that the new acquisitions in terms of the myelin trophic function allow envisaging a novel neuroprotectant strategy, focused on sustaining its aerobic metabolism.&picture=http://www.aascit.org/aascit/decorators/img/journal/908.jpg)
| [1] | Isabella Panfoli, DIFAR-Biochemistry Lab., School of Medical and Pharmaceutical Sciences, University of Genova, Genova, Italy. |
| [2] | Daniela Calzia, DIFAR-Biochemistry Lab., School of Medical and Pharmaceutical Sciences, University of Genova, Genova, Italy. |
| [3] | Cesare Santi, Private Practice, Milano, Italy. |
There is a high prevalence in the population, of olfactory dysfunction, a condition severely affecting quality of life. Here we present a sample of two patients presenting with anosmia with a duration of more than 12 months, for whom classical treatments were ineffective. The first patient was a 36 year-old male and the second a 52 year-old male. Both had a complete clinical assessment, psychophysical testing of olfactory function, and otorhinolaryngological examination including nasal endoscopy, which did not reveal any pathology. The first patient underwent brain computed tomography (CT), and magnetic resonance imaging, while the other just CT scan, both inexpressive. The etiologic diagnose were idiopathic and secondary to acute rhinitis, respectively. Both patients had been treated with topical steroids and anti-histaminic drugs. Our treatment of this condition was dietary integration with galactose (1.5 g), reduced glutathione (0.1 g) and Ubiquinone (Coenzyme Q10, 0.1 g). For assessment of response to treatment, the Italian version of the University of Pennsylvania Smell Identification Test was used. After two months treatment the older patient completely recovered smell and was also able to appreciate some tastes. The younger patient, after one-month treatment experienced cacosmia, and some phantosmia, but after one more month treatment, such symptoms disappeared and he recovered partially normal smell and gustative function. In both cases, the recovery is stable, until now. Results suggest that the new acquisitions in terms of the myelin trophic function allow envisaging a novel neuroprotectant strategy, focused on sustaining its aerobic metabolism.
Keywords
Anosmia, Galactose, Glutathione, Myelin, Neuroprotection, Olfaction
Reference
| [01] | C. Murphy, C. R. Schubert, K. J. Cruickshanks, B. E. K. Klein, R. Klein, D. M. Nondahl, Prevalence of olfactory impairment in older adults., JAMA. 288 (2002) 2307–12. http://www.ncbi.nlm.nih.gov/pubmed/12425708 (accessed July 31, 2017). |
| [02] | A. F. P. Temmel, C. Quint, B. Schickinger-Fischer, L. Klimek, E. Stoller, T. Hummel, et al., Characteristics of Olfactory Disorders in Relation to Major Causes of Olfactory Loss, Arch. Otolaryngol. Neck Surg. 128 (2002) 635. doi: 10.1001/archotol.128.6.635. |
| [03] | D. Jennings, A. Siderowf, M. Stern, J. Seibyl, S. Eberly, D. Oakes, et al., Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study, Neurology. 83 (2014) 1739–1746. doi: 10.1212/WNL.0000000000000960. |
| [04] | T. Hummel, J. Lotsch, Prognostic Factors of Olfactory Dysfunction, Arch. Otolaryngol. - Head Neck Surg. 136 (2010) 347–351. doi: 10.1001/archoto.2010.27. |
| [05] | R. L. Doty, P. Shaman, C. P. Kimmelman, M. S. Dann, University of pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic, Laryngoscope. 94 (1984) 176–178. doi: 10.1288/00005537-198402000-00004. |
| [06] | M. Picillo, A. Iavarone, M. T. Pellecchia, M. Amboni, R. Erro, M. Moccia, et al., Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: Our experience on one hundred and thirty-eight healthy subjects, Clin. Otolaryngol. 39 (2014) 53–57. doi: 10.1111/coa.12212. |
| [07] | L. Silveira-Moriyama, A. M.. Azevedo, R. Ranvaud, E. R. Barbosa, R. L. Doty, A. J. Lees, Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil, Arq. Neuropsiquiatr. 68 (2010) 700–705. doi: 10.1590/S0004-282X2010000500005. |
| [08] | F. Fleiner, O. Goktas, Topical beclomethasone in the therapy of smelling disorders-a new application technique., Indian J. Otolaryngol. Head Neck Surg. 63 (2011) 5–9. doi: 10.1007/s12070-010-0063-z. |
| [09] | A. Obando, I. Alobid, F. Gastón, J. Berenguer, C. Marin, J. Mullol, Should postviral anosmia be further investigated?, Allergy. 64 (2009) 1556–1557. doi: 10.1111/j.1398-9995.2009.02092.x. |
| [10] | K. A. Nave, Myelination and the trophic support of long axons, Nat Rev Neurosci. 11 (2010) 275–283. doi: 10.1038/nrn2797nrn2797 [pii]. |
| [11] | S. Ravera, I. Panfoli, D. Calzia, M. G. Aluigi, P. Bianchini, A. Diaspro, et al., Evidence for aerobic ATP synthesis in isolated myelin vesicles, Int J Biochem Cell Biol. 41 (2009) 1581–1591. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19401152. |
| [12] | S. Ravera, I. Panfoli, M. G. Aluigi, D. Calzia, A. Morelli, Characterization of Myelin Sheath F(o)F(1)-ATP synthase and its regulation by IF(1), Cell Biochem Biophys. 59 (2011) 63–70. |
| [13] | S. Ravera, L. Nobbio, D. Visigalli, M. Bartolucci, D. Calzia, F. Fiorese, et al., Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy, J Neurochem. 126 (2013) 82–92. doi: 10.1111/jnc.12253. |
| [14] | S. Ravera, M. Bartolucci, D. Calzia, M. G. Aluigi, P. Ramoino, A. Morelli, et al., Tricarboxylic acid cycle-sustained oxidative phosphorylation in isolated myelin vesicles, Biochimie. (2013). doi: S0300-9084(13)00212-5 [pii]10.1016/j.biochi.2013.07.003. |
| [15] | R. S. Bartolucci M, Ramoino P, Calzia D, Traverso C, Panfoli I., Oxydative Metabolism in Optic Nerve Myelin: New Perspectives in Hereditary Optic Neuropathies, Clin. J. Ophthalmol. 1 (2014) in press. |
| [16] | A. Morelli, S. Ravera, I. Panfoli, Hypothesis of an Energetic Function for Myelin, Cell Biochem Biophys. (2011). doi: 10.1007/s12013-011-9174-8. |
| [17] | S. Ravera, I. Panfoli, Role of myelin sheath energy metabolism in neurodegenerative diseases., Neural Regen. Res. 10 (2015) 1570–1. doi: 10.4103/1673-5374.167749. |
| [18] | S. Ravera, M. Bartolucci, D. Calzia, A. Morelli, I. Panfoli, Galactose and Hexose 6–Phosphate Dehydrogenase Support the Myelin Metabolic Role., PARIPEX-Indian J. Res. IV (2015) 397–400. http://worldwidejournals.com/paripex/articles.php?val=NDA5Mw==&b1=397&k=100 (accessed November 16, 2015). |
| [19] | L. Lobato Gregorio, F. Caparroz, L. M. A. Nunes, L. R. Neves, E. K. Macoto, Olfaction disorders: retrospective study✩✩Please cite this article as: Gregorio LL, Caparroz F, Nunes LM, Neves LR, Macoto EK. Olfaction disorders: retrospective study. Braz J Otorhinolaryngol. 2014; 80: 11-7., Braz. J. Otorhinolaryngol. 80 (2014) 11–17. doi: 10.5935/1808-8694.20140005. |
| [20] | J. H. Brann, S. J. Firestein, A lifetime of neurogenesis in the olfactory system., Front. Neurosci. 8 (2014) 182. doi: 10.3389/fnins.2014.00182. |
